- call +1-201-465-4211
- email sales@mrinsights.biz
Infectious disease diagnostics involves identifying the presence of foreign antigen/organism using diagnostic tools such as kits. Most of the standard diagnostic test kits currently available are for bacterial infections and sexually transmitted diseases. However, in future these diagnostic tests are expected to be replaced by molecular techniques.
Scope of the Report:
The global infectious disease diagnostic market is expected to witness significant growth during the forecast period due to increasing prevalence of infectious diseases, increased funding from various government and private organizations, and increasing demand for new diagnostic tests for the control of infectious diseases.
The global Infectious Disease Diagnostic market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Infectious Disease Diagnostic.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Infectious Disease Diagnostic market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Infectious Disease Diagnostic market by product type and applications/end industries.
Market Segment by Companies, this report covers
F. Hoffmann-La Roche Ltd
BioMrieux SA
Bio-Rad Laboratories, Inc
Danaher Corporation
Becton
Dickinson and Company
Cepheid
Alere
DiaSorin S.p.A.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Instruments
Consumables
Software and Services
Market Segment by Applications, can be divided into
Hepatitis B virus (HBV)
Hepatitis C virus (HCV)
Acquired Immunodeficiency Syndrome (AIDS)
Tuberculosis (TB)
Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
Human Papillomavirus (HPV) infection
Others
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Infectious Disease Diagnostic Market Overview
1.1 Product Overview and Scope of Infectious Disease Diagnostic
1.2 Classification of Infectious Disease Diagnostic by Types
1.2.1 Global Infectious Disease Diagnostic Revenue Comparison by Types (2017-2023)
1.2.2 Global Infectious Disease Diagnostic Revenue Market Share by Types in 2017
1.2.3 Instruments
1.2.4 Consumables
1.2.5 Software and Services
1.3 Global Infectious Disease Diagnostic Market by Application
1.3.1 Global Infectious Disease Diagnostic Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Hepatitis B virus (HBV)
1.3.3 Hepatitis C virus (HCV)
1.3.4 Acquired Immunodeficiency Syndrome (AIDS)
1.3.5 Tuberculosis (TB)
1.3.6 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
1.3.7 Human Papillomavirus (HPV) infection
1.3.8 Others
1.4 Global Infectious Disease Diagnostic Market by Regions
1.4.1 Global Infectious Disease Diagnostic Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Infectious Disease Diagnostic Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Infectious Disease Diagnostic Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Infectious Disease Diagnostic Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Infectious Disease Diagnostic Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Infectious Disease Diagnostic Status and Prospect (2013-2023)
1.5 Global Market Size of Infectious Disease Diagnostic (2013-2023)
2 Manufacturers Profiles
2.1 F. Hoffmann-La Roche Ltd
2.1.1 Business Overview
2.1.2 Infectious Disease Diagnostic Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 F. Hoffmann-La Roche Ltd Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.2 BioMrieux SA
2.2.1 Business Overview
2.2.2 Infectious Disease Diagnostic Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 BioMrieux SA Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bio-Rad Laboratories, Inc
2.3.1 Business Overview
2.3.2 Infectious Disease Diagnostic Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bio-Rad Laboratories, Inc Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.4 Danaher Corporation
2.4.1 Business Overview
2.4.2 Infectious Disease Diagnostic Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Danaher Corporation Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.5 Becton
2.5.1 Business Overview
2.5.2 Infectious Disease Diagnostic Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Becton Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.6 Dickinson and Company
2.6.1 Business Overview
2.6.2 Infectious Disease Diagnostic Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Dickinson and Company Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.7 Cepheid
2.7.1 Business Overview
2.7.2 Infectious Disease Diagnostic Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Cepheid Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.8 Alere
2.8.1 Business Overview
2.8.2 Infectious Disease Diagnostic Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Alere Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
2.9 DiaSorin S.p.A.
2.9.1 Business Overview
2.9.2 Infectious Disease Diagnostic Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 DiaSorin S.p.A. Infectious Disease Diagnostic Revenue, Gross Margin and Market Share (2016-2017)
3 Global Infectious Disease Diagnostic Market Competition, by Players
3.1 Global Infectious Disease Diagnostic Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Infectious Disease Diagnostic Players Market Share
3.2.2 Top 10 Infectious Disease Diagnostic Players Market Share
3.3 Market Competition Trend
4 Global Infectious Disease Diagnostic Market Size by Regions
4.1 Global Infectious Disease Diagnostic Revenue and Market Share by Regions
4.2 North America Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
4.3 Europe Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
4.5 South America Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
5 North America Infectious Disease Diagnostic Revenue by Countries
5.1 North America Infectious Disease Diagnostic Revenue by Countries (2013-2018)
5.2 USA Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
5.3 Canada Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
5.4 Mexico Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
6 Europe Infectious Disease Diagnostic Revenue by Countries
6.1 Europe Infectious Disease Diagnostic Revenue by Countries (2013-2018)
6.2 Germany Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
6.3 UK Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
6.4 France Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
6.5 Russia Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
6.6 Italy Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Infectious Disease Diagnostic Revenue by Countries
7.1 Asia-Pacific Infectious Disease Diagnostic Revenue by Countries (2013-2018)
7.2 China Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
7.3 Japan Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
7.4 Korea Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
7.5 India Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
8 South America Infectious Disease Diagnostic Revenue by Countries
8.1 South America Infectious Disease Diagnostic Revenue by Countries (2013-2018)
8.2 Brazil Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
8.3 Argentina Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
8.4 Colombia Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Infectious Disease Diagnostic by Countries
9.1 Middle East and Africa Infectious Disease Diagnostic Revenue by Countries (2013-2018)
9.2 Saudi Arabia Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
9.3 UAE Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
9.4 Egypt Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
9.5 Nigeria Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
9.6 South Africa Infectious Disease Diagnostic Revenue and Growth Rate (2013-2018)
10 Global Infectious Disease Diagnostic Market Segment by Type
10.1 Global Infectious Disease Diagnostic Revenue and Market Share by Type (2013-2018)
10.2 Global Infectious Disease Diagnostic Market Forecast by Type (2018-2023)
10.3 Instruments Revenue Growth Rate (2013-2023)
10.4 Consumables Revenue Growth Rate (2013-2023)
10.5 Software and Services Revenue Growth Rate (2013-2023)
11 Global Infectious Disease Diagnostic Market Segment by Application
11.1 Global Infectious Disease Diagnostic Revenue Market Share by Application (2013-2018)
11.2 Infectious Disease Diagnostic Market Forecast by Application (2018-2023)
11.3 Hepatitis B virus (HBV) Revenue Growth (2013-2018)
11.4 Hepatitis C virus (HCV) Revenue Growth (2013-2018)
11.5 Acquired Immunodeficiency Syndrome (AIDS) Revenue Growth (2013-2018)
11.6 Tuberculosis (TB) Revenue Growth (2013-2018)
11.7 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG) Revenue Growth (2013-2018)
11.8 Human Papillomavirus (HPV) infection Revenue Growth (2013-2018)
11.9 Others Revenue Growth (2013-2018)
12 Global Infectious Disease Diagnostic Market Size Forecast (2018-2023)
12.1 Global Infectious Disease Diagnostic Market Size Forecast (2018-2023)
12.2 Global Infectious Disease Diagnostic Market Forecast by Regions (2018-2023)
12.3 North America Infectious Disease Diagnostic Revenue Market Forecast (2018-2023)
12.4 Europe Infectious Disease Diagnostic Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Infectious Disease Diagnostic Revenue Market Forecast (2018-2023)
12.6 South America Infectious Disease Diagnostic Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Infectious Disease Diagnostic Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Infectious Disease Diagnostic Picture
Table Product Specifications of Infectious Disease Diagnostic
Table Global Infectious Disease Diagnostic and Revenue (Million U
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
